<qa>  What is the name of the humanised monoclonal antibody linked to?Cancers arising from an organ can be cured in some cases with various combinations of surgery, chemotherapy and radiotherapy. However, once some cancers spread, treatment with conventional methods is unlikely to cure the cancer and treatment is designed to control the growth of the cancer and the problems it is causing. This is a clinical trial of a drug called CMD-193 which is a humanised monoclonal antibody linked to a toxin calicheamicin. The experimental treatment approach used here involves targeting a marker antigen called the Lewis-y antigen on the tumour cells surface with a specially constructed humanised monoclonal antibody. This antibody delivers a toxin calicheamicin into the tumour cell and this may kill the tumour cell. 